N-Acetylcysteine (NAC)

TL;DR — NAC is a well-characterized cysteine donor that refills the rate-limiting substrate for glutathione (GSH) synthesis. It has decades of approved human use as a mucolytic and as the antidote for acetaminophen poisoning, so its safety and pharmacology are unusually well understood for a supplement. The longevity case is weaker and largely indirect: the strongest human aging data come from GlyNAC (NAC combined with glycine), not NAC alone. Treat standalone NAC as Tier B — solid mechanism and safety, thin direct healthspanThe portion of life spent in good health, free from chronic disease or disability — distinct from lifespan (total years alive). Full glossary → evidence. Typical dose 600–1,800 mg/day.

01What NAC does (and why it matters)

GlutathioneYour body's most abundant internal antioxidant, made from glycine, cysteine, and glutamate. Full glossary → is the cell's dominant intracellular antioxidant and a substrate for the antioxidant enzymes that clear peroxides and reactive electrophiles. Its synthesis is rate-limited by cysteine availability, and free cysteine is scarce and unstable in plasma. NAC is an acetylated, stable form of cysteine: it survives first-pass, is deacetylated to cysteine, and feeds glutamate-cysteine ligase — the rate-limiting enzyme of GSH synthesis. In aging, tissue GSH tends to fall, in part because synthesis capacity declines; restoring the substrate pool is the mechanistic rationale for NAC in a longevity context.

Primary hallmarks targeted: Loss of proteostasis · Chronic inflammation · Mitochondrial dysfunction

02Mechanism — a substrate, not a signaling drug

NAC works mostly by mass action on a depleted pathway rather than by activating a receptor or transcription factor.

The mechanistic and approved-use literature is strong. Bavarsad Shahripour et al. 2014 (PMID 24683506, Brain Behav) reviews NAC's antioxidant and glutamatergic actions; Licata et al. 2022 (PMID 36034775, Front Pharmacol) reviews NAC as the standard antidote for acetaminophen-induced liver injury when given within ~8 h. Both confirm the biochemistry — neither is a longevity claim.

03Evidence summary

Consensus: Tier B. NAC's biochemistry and safety are genuinely well established, and there is real — if modest and mixed — human RCT signal in psychiatry. But the aging-specific human evidence is for GlyNAC, and the one lifelong mouse lifespan study extended male lifespan in a way the authors attributed largely to reduced food intake rather than a clean pharmacological effect. That is honest Tier B territory, not Tier A: strong mechanism, thin isolated healthspan data.

04Dosing protocol

05Monitoring

06Safety, red flags, and contraindications

• Generally well tolerated — decades of mucolytic and antidote use give NAC an unusually mature safety record for a supplement.
• GI effects — nausea, and occasional cramping/diarrhea; Berk 2014 noted more GI and musculoskeletal complaints on NAC than placebo. Take with food and split the dose if needed.

• Consult a physician before combining with prescription medication, especially nitrates or anticoagulants.
• The regulatory status of oral NAC as a supplement has been contested by the FDA; source from reputable suppliers.

What would change this grade. NAC is B. A trial isolating NAC alone against a healthspan endpoint would clarify how much it contributes independent of glycine — right now the evidence keeps pointing to the combination. It stays capped until standalone aging data exist.

07Synergies and antagonists

Pairs well with:

Works against / redundant with:

08Personal results template